Posizioni attive di Jason Criscione
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Ansella Therapeutics, Inc.
 Ansella Therapeutics, Inc. BiotechnologyHealth Technology Ansella Therapeutics, Inc. develops therapeutic solutions for women's vaginal health. The company is based in Lowell, MA. The company was founded by Mark Goldstone. | Direttore/Membro del Consiglio | - | - |
Enquyst Technologies Inc.
 Enquyst Technologies Inc. Medical SpecialtiesHealth Technology Enquyst Technologies Inc. is a company that is focused on developing next-generation biomanufacturing technology solutions to make life-changing and curative treatments more accessible and affordable for patients worldwide. The company is based in Lowell, MA and was founded by Jason Criscione. The company's patented technology is being applied to solve large unmet needs in the downstream purification of gene therapies, particularly AAV and lentiviral vector-based gene therapies. | Direttore Tecnico/Scientifico/R&S | 01/04/2017 | - |
| Fondatore | 01/04/2017 | - |
Storia della carriera di Jason Criscione
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Ansella Therapeutics, Inc.
Ansella Therapeutics, Inc. BiotechnologyHealth Technology Ansella Therapeutics, Inc. develops therapeutic solutions for women's vaginal health. The company is based in Lowell, MA. The company was founded by Mark Goldstone. | Health Technology |
Enquyst Technologies Inc.
Enquyst Technologies Inc. Medical SpecialtiesHealth Technology Enquyst Technologies Inc. is a company that is focused on developing next-generation biomanufacturing technology solutions to make life-changing and curative treatments more accessible and affordable for patients worldwide. The company is based in Lowell, MA and was founded by Jason Criscione. The company's patented technology is being applied to solve large unmet needs in the downstream purification of gene therapies, particularly AAV and lentiviral vector-based gene therapies. | Health Technology |
- Borsa valori
- Insiders
- Jason Criscione
- Esperienza
